|
![]() |
|||
|
||||
OverviewHazelden's bestselling program for addressing and treating co-occurring disorders is now better than ever. Updated to meet DSM-5 classifications, and with a beautiful new design, new titles that help you immediately find what you need, this evidence-based program addresses issues that directly impact clients living with a substance use disorder and non-severe mental illness. Medication Management is written specifically for physicians, clinicians, and other medical staff and focuses on the knowledge and skills for medication treatment of clients living with a co-occurring disorder. Evidence- and consensus-based practices are provided to help medical personnel make informed decisions about prescribing medications. Part 1 covers: psychiatric symptoms of intoxication and withdrawal; general principles of medication management; treatment strategies tailored to the stages of change; ways to collaborate with the client to prepare a medication plan; and techniques to encourage clients’ adherence to the medication plan. Part 2 is a comprehensive medication reference that includes information about specific medications used to treat patients with co-occurring disorders. The accompanying CD-ROM includes information sheets on specific medications as well as reproducible client handouts. Full Product DetailsAuthor: Developed by faculty from the Giesel School of Medicine at DartmouthPublisher: Hazelden Information & Educational Services Imprint: Hazelden Information & Educational Services Edition: Revised Edition Weight: 0.354kg ISBN: 9781616495459ISBN 10: 1616495456 Pages: 101 Publication Date: 30 November 2014 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Temporarily unavailable ![]() The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you. Table of ContentsReviewsAuthor InformationThe authors are national leaders in the research and treatment of co-occurring disorders from the Geisel School of Medicine at Dartmouth. They include Mark McGovern, Ph.D., Robert E. Drake, M.D., Ph.D., Matthew R. Merrens, Ph.D., Kim T. Mueser, Ph.D., and Mary F. Brunette, M.D. Tab Content 6Author Website:Countries AvailableAll regions |